EXHIBIT 4.30


 


 


AGENT WARRANT CERTIFICATE


 


THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, OR THE SECURITIES LAWS OF ANY STATE. THEY MAY NOT
BE SOLD, OR OFFERED FOR SALE, IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES, OR AN OPINION OF COUNSEL
OR OTHER EVIDENCE ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.


 


THE TRANSFER OR EXCHANGE OF THE WARRANTS REPRESENTED BY THIS
CERTIFICATE IS RESTRICTED IN ACCORDANCE WITH THE AGENT WARRANT AGREEMENT REFERRED TO HEREIN.


 


	No. AW- 2013-001	75,000 Warrants


 


This Agent Warrant Certificate certifies that
Cantone Research, Inc., or its assigns, is the Holder of Seventy Five Thousand (75,000) Warrants (the “Agent Warrants”)
to purchase initially, at any time after the date hereof until 5:00 p.m. Eastern Time on August 1, 2016, (“Expiration
Date”), up to Seventy Five Thousand (75,000) shares of common stock (“Common Stock”), of American Bio
Medica Corporation, a New York corporation (the “Company”), at the exercise price of $0.14 per share of Common
Stock (“Exercise Price”) upon surrender of this Agent Warrant Certificate and payment of the Exercise Price, subject
to the conditions set forth herein and in the Placement Agent Warrant Agreement dated October 7, 2013 between the Company and Cantone
Research, Inc. (the “Warrant Agreement”). Capitalized terms used herein and not defined herein shall have the meanings
ascribed to such terms by the Warrant Agreement. Payment of the Exercise Price shall be in the form of a certified or bank cashier’s
check payable to the order of the Company in an amount equal to the Exercise Price multiplied by the number of Agent Warrants being
exercised.


 


The Agent Warrants may be exercised only
to the extent that the Company shall have delivered Series A Debentures and received the net purchase price therefore. No
Warrant may be exercised after 5:00 p.m., Eastern Time, on the Expiration Date, at which time all Agent Warrants evidenced hereby,
unless exercised prior thereto, hereby shall thereafter be void.


 


The Agent Warrants evidenced by this Agent
Warrant Certificate are part of a duly authorized issue of Agent Warrants issued pursuant to the Warrant Agreement, which Warrant
Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a description
of the rights, limitations of rights, obligations, duties and immunities thereunder of the Company and the Holders of the Agent
Warrants.


 


Upon due presentment for registration of transfer
of this Agent Warrant Certificate and executed form of assignment as attached hereto at the office of the Company set forth in
the Warrant Agreement, a new Agent Warrant Certificate or Agent Warrant Certificates of like tenor and evidencing in the aggregate
a like number of Agent Warrants shall be issued to the transferee(s) in exchange for this Agent Warrant Certificate, subject to
the limitations provided herein and in the Warrant Agreement, without any charge except for any tax or other governmental charge
imposed in connection with such transfer.


 


Upon the exercise of less than all of the
Agent Warrants evidenced by this Certificate, the Company shall forthwith issue to the holder hereof a new Agent Warrant Certificate
representing such unexercised Agent Warrants.


 




    	 



    	 



    

 


The Company may deem and
treat the Holder(s) hereof as reflected on the records of the Company as the absolute owner(s) of this Agent Warrant Certificate
(notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, and
of any distribution to the Holder(s) hereof, and for all other purposes, and the Company shall not be affected by any notice to
the contrary.


 


IN WITNESS WHEREOF, the Company has caused this Agent
Warrant Certificate to be duly executed under its corporate seal.


 


Dated as of October 7, 2013


 


American Bio Medica Corporation


 


	/S/ Melissa A. Waterhouse	 
	BY: Melissa A. Waterhouse	 
	ITS: EVP, CCO, SEC	 


 


(CORPORATE SEAL)


 




    	 



    	 



    

 


ELECTION TO PURCHASE


 


The undersigned hereby irrevocably elects
to exercise the right, represented by this Warrant Certificate, to purchase ___________ Shares of Common Stock.


 


In accordance with the terms of Section 3.1 of the Placement
Agent Warrant Agreement dated as of October 7, 2013, between American Bio Medica Corporation and Cantone Research, Inc., the undersigned
requests that a certificate for such Common Stock be registered in the name of _________________________________________, whose
address is ___________________________________________________________ and that such Certificate be delivered to ____________________________________        
whose address is _______________________________________________________.


 


Dated: _________________, 20____


 


Signature:


 


	 	 


BY:


ITS:


(Signature must conform in all respects to name of holder as
specified on the face of the Warrant Certificate.)


 


	 	 


(Insert Social Security or Other Identifying Number of Holder)


 




    	 



    	 



    

 


ASSIGNMENT


 


(To be executed by the Holder if such Holder to transfer the
Agent Warrant Certificate.)


 


FOR VALUE RECEIVED


 


_____________________________________________________ hereby
sells, assigns and transfers unto


 


	 
	 
	 


(Please print name and address of transferee)


 


this Agent Warrant Certificate, together with all right, title
and interest therein, and does hereby authorize the transfer of the within Warrant Certificate on the books of American Bio Medica
Corporation, with full power of substitution.


 


Dated:


 


	 	 


 


Signature:


 


	 	 


(Signature must conform in all respects to name of holder as
specified on the face of the Warrant Certificate.)


 


	 	 


(Insert Social Security or Other Identifying Number of Holder)